Novelties in the treatment of inflammatory bowel disease: outcome of the symposium 213 by the Falk Foundation
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 2
Abstract
-
Authors and Affiliations
O. G. Kurinna
Keywords
Related Articles
- EP ID EP575158
- DOI -
- Views 121
- Downloads 0
The investigation of herbal medicine Holelesan® in patients with functional pathology of biliary system and intestine
Objective — to investigate efficacy of the herbal drug Holelesan® in the treatment of patients with functional diseases of the biliary tract (FDBT) in combination with irritable bowel syndrome with constipation (IBS-C)....
Functional dyspepsia and immune dysfunction: modern concepts of pathogenetic mechanisms of their development
The review presents the main modern opinions on the immunological factors of functional dyspepsia development and data on its micromorphological basis. The immune dysfunction is considered as an important factor in the p...
New directions in the treatment of irritable bowel syndrome: focus on microbiosis
Fecal transplantation (FT) is the process of transplanting purified fecal material from a healthy donor to a recipient. The available evidence confirmed the positive role of FT in the treatment of a number of diseases, i...
Effects of non-drug treatment on the parameters of carbohydrate metabolism in patients with non-alcoholic fatty liver disease and obesity
Objective — to determine the efficacy of the complex non-drug treatment (NDT) on the course of non-alcoholic fatty liver disease (NAFLD) in patients with the concomitant obesity and on the associated disorders of the car...
A place of plasma substitutes in the treatment of patients with chronic viral hepatitis
Objective — to assess the efficacy of plasma substitute (Reosorbilact) in patients with chronic viral hepatitis. Materials and methods. The investigation involved 60 patients with chronic viral hepatitis (CVH), who were...